[
  {
    "ts": null,
    "headline": "Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines",
    "summary": "Insulet stock surged 50% in 6 months due to strong Q3 earnings and expanded market potential. Despite impressive growth, high expectations and competition pose risks to future performance.",
    "url": "https://finnhub.io/api/news?id=8e095118027c858d5861dba2565e08c0f2eaaa28b5fc0aea58506b96893e1a68",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732127168,
      "headline": "Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines",
      "id": 131521237,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/79122847/image_79122847.jpg?io=getty-c-w1536",
      "related": "PODD",
      "source": "SeekingAlpha",
      "summary": "Insulet stock surged 50% in 6 months due to strong Q3 earnings and expanded market potential. Despite impressive growth, high expectations and competition pose risks to future performance.",
      "url": "https://finnhub.io/api/news?id=8e095118027c858d5861dba2565e08c0f2eaaa28b5fc0aea58506b96893e1a68"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.",
    "summary": "ACTON, Mass., November 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery (AID) System is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the U.S. This makes Omnipod 5 the most connected tubeless AID system in the U.S.",
    "url": "https://finnhub.io/api/news?id=c110dc9cb1152ad51448039011a08ceef9895677f3802c78af0aa847f097e4ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732109400,
      "headline": "Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.",
      "id": 131516385,
      "image": "https://media.zenfs.com/en/business-wire.com/2f3bfdf08449816ab186f5388a05f614",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "ACTON, Mass., November 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery (AID) System is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the U.S. This makes Omnipod 5 the most connected tubeless AID system in the U.S.",
      "url": "https://finnhub.io/api/news?id=c110dc9cb1152ad51448039011a08ceef9895677f3802c78af0aa847f097e4ef"
    }
  }
]